Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome.
about
Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid.Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.Maternal and congenital toxoplasmosis, currently available and novel therapies in horizonMaternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers.Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcomeMechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and ProspectsCharacterization of alpha-fetoprotein levels in three dolphin species: development of sensitive immunoassays for analysis of the pregnancy-associated variations.Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets.Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.Autism Spectrum Disorder Risk in Relation to Maternal Mid-Pregnancy Serum Hormone and Protein Markers from Prenatal Screening in California.Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.Amniotic fluid α-fetoprotein microheterogeneity in the prenatal diagnosis of congenital disorders of glycosylation type Ia.Autism spectrum disorders and maternal serum α-fetoprotein levels during pregnancy.Biochemical screening for aneuploidy in patients with donor oocyte pregnancies compared with autologous pregnancies.Fetomaternal and Pediatric Toxoplasmosis.Obstructive sleep apnea is associated with alterations in markers of fetoplacental wellbeing.
P2860
Q33317779-F35DD3A3-D98D-4641-BD9D-312CAF00F600Q33723687-229A782E-0F98-4291-BDFE-E6F7753D935CQ33943894-4F26F052-D15C-4FA2-9096-E9D4A02E6D7FQ36439778-75AC36B2-A710-4EE3-B03D-C968AA27FA54Q36740183-7AF2B818-A68B-4FE7-9EAC-6E0CD5D2A605Q36901631-99CE25DA-683C-410D-9095-7E4EDAE23AACQ36957465-4BF72EE7-11D6-4353-B1E6-69D00DE3FD5AQ37132813-41150E6D-A72D-40C3-95A5-E0CF9FCA8917Q37620848-0D00D67E-591F-4D95-BD13-360DE3D2F5C5Q37814204-0884EC9A-CB11-4501-9F35-DFABAFC32D4DQ38375985-D6419239-673C-45B9-9A24-9E9837EB7BC5Q38969084-6455CF15-1BA6-4EB2-AAAF-14597FFCD86CQ40539414-0035DB16-6C39-4BAF-B2D4-07EE8196935BQ41128106-511014D9-C379-4A57-AD8F-63EDC30E5CC7Q43042911-69AE49D5-F5AB-4F4B-A8F7-2E48AA92EFC3Q43530528-2224DE3C-BFB9-412C-8D21-F7FD860164C5Q46537104-3C1DFCC0-1DAB-42D7-A08C-35FCD5E938F7Q47565444-1DEB36CE-A751-4EB2-B4D4-C2E5AD252DE3Q48114572-5E8AABBB-C00E-48E1-B20D-D041F80D2634
P2860
Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Physiology of alpha-fetoprotei ...... to adverse pregnancy outcome.
@en
type
label
Physiology of alpha-fetoprotei ...... to adverse pregnancy outcome.
@en
prefLabel
Physiology of alpha-fetoprotei ...... to adverse pregnancy outcome.
@en
P2860
P356
P1476
Physiology of alpha-fetoprotei ...... to adverse pregnancy outcome.
@en
P2093
Gerald J Mizejewski
P2860
P304
P356
10.3181/0612-MR-291
P577
2007-09-01T00:00:00Z